Related Experiment Video
Updated: Jan 19, 2026
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Analysis of compliance to antiretroviral treatment among patients with HIV/AIDS
Hélia Carla de Souza1, Márcio Rabelo Mota1,2, Amanda Ribeiro Alves1
1Centro Universitário de Brasília. Brasília, Distrito Federal, Brazil.
Objective:
To analyze the compliance to antiretroviral therapy among HIV/AIDS patients.
Method:
99 HIV-positive volunteers undergoing treatment responded to a semi-structured sociodemographic interview and to a questionnaire that assessed compliance to antiretroviral treatment.
Results:
In the sample analyzed, 52.5% of the volunteers presented good/adequate treatment compliance, while 33.3% presented low/insufficient compliance. There was no significant difference between men and women in the questionnaire score, nor between groups with different levels of education.
Conclusion:
The main items of the questionnaire that contributed to good/adequate compliance were: positive impact of treatment on health and quality of life, few side effects after initiation of therapy, and positive self-evaluation of participants regarding their compliance to antiretroviral therapy. The main barriers detected for compliance to antiretroviral therapy were the lack of knowledge about current medications and the lack of information on antiretroviral therapy drugs.
Related Concept Videos
06:07Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
23:56Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
11:10Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
04:19Oral Combinational Antiretroviral Therapy to Treat HIV-1 Infection in a Humanized Mouse Model
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty